The Strategic Outsourcing: How Contract Manufacturing Organizations (CMOs) Are Driving Drug Development
The development and manufacturing of biologic drugs is a complex and capital-intensive endeavor. Contract Manufacturing Organizations (CMOs) specializing in biologics fill-finish have emerged as a strategic solution for pharmaceutical companies of all sizes. The global biologics fill-finish services market, valued at USD 9.3 billion in 2025 and projected to grow to USD 15.0 billion by...
0 التعليقات 0 المشاركات 4 مشاهدة 0 معاينة